These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 33154372)

  • 1. Engineering microrobots for targeted cancer therapies from a medical perspective.
    Schmidt CK; Medina-Sánchez M; Edmondson RJ; Schmidt OG
    Nat Commun; 2020 Nov; 11(1):5618. PubMed ID: 33154372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinspired microrobots: Opportunities and challenges in targeted cancer therapy.
    Singh AK; Awasthi R; Malviya R
    J Control Release; 2023 Feb; 354():439-452. PubMed ID: 36669531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
    Bar-Zeev M; Livney YD; Assaraf YG
    Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically engineered bacteria: a new frontier in targeted drug delivery.
    Fooladi S; Rabiee N; Iravani S
    J Mater Chem B; 2023 Nov; 11(42):10072-10087. PubMed ID: 37873584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escherichia coli Nissle 1917-driven microrobots for effective tumor targeted drug delivery and tumor regression.
    Wu D; Zhao Z; Liu H; Fu K; Ji Y; Ji W; Li Y; Yan Q; Yang G
    Acta Biomater; 2023 Oct; 169():477-488. PubMed ID: 37532134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in refunctionalization of erythrocyte-based nanomedicine for enhancing cancer-targeted drug delivery.
    Sun D; Chen J; Wang Y; Ji H; Peng R; Jin L; Wu W
    Theranostics; 2019; 9(23):6885-6900. PubMed ID: 31660075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bubble-Based Microrobots with Rapid Circular Motions for Epithelial Pinning and Drug Delivery.
    Lee JG; Raj RR; Thome CP; Day NB; Martinez P; Bottenus N; Gupta A; Wyatt Shields C
    Small; 2023 Aug; 19(32):e2300409. PubMed ID: 37058137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers.
    Aghebati-Maleki A; Dolati S; Ahmadi M; Baghbanzhadeh A; Asadi M; Fotouhi A; Yousefi M; Aghebati-Maleki L
    J Cell Physiol; 2020 Mar; 235(3):1962-1972. PubMed ID: 31441032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
    Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
    Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facile Fabrication of Magnetic Microrobots Based on Spirulina Templates for Targeted Delivery and Synergistic Chemo-Photothermal Therapy.
    Wang X; Cai J; Sun L; Zhang S; Gong D; Li X; Yue S; Feng L; Zhang D
    ACS Appl Mater Interfaces; 2019 Feb; 11(5):4745-4756. PubMed ID: 30638360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse Applications of Nanomedicine.
    Pelaz B; Alexiou C; Alvarez-Puebla RA; Alves F; Andrews AM; Ashraf S; Balogh LP; Ballerini L; Bestetti A; Brendel C; Bosi S; Carril M; Chan WC; Chen C; Chen X; Chen X; Cheng Z; Cui D; Du J; Dullin C; Escudero A; Feliu N; Gao M; George M; Gogotsi Y; Grünweller A; Gu Z; Halas NJ; Hampp N; Hartmann RK; Hersam MC; Hunziker P; Jian J; Jiang X; Jungebluth P; Kadhiresan P; Kataoka K; Khademhosseini A; Kopeček J; Kotov NA; Krug HF; Lee DS; Lehr CM; Leong KW; Liang XJ; Ling Lim M; Liz-Marzán LM; Ma X; Macchiarini P; Meng H; Möhwald H; Mulvaney P; Nel AE; Nie S; Nordlander P; Okano T; Oliveira J; Park TH; Penner RM; Prato M; Puntes V; Rotello VM; Samarakoon A; Schaak RE; Shen Y; Sjöqvist S; Skirtach AG; Soliman MG; Stevens MM; Sung HW; Tang BZ; Tietze R; Udugama BN; VanEpps JS; Weil T; Weiss PS; Willner I; Wu Y; Yang L; Yue Z; Zhang Q; Zhang Q; Zhang XE; Zhao Y; Zhou X; Parak WJ
    ACS Nano; 2017 Mar; 11(3):2313-2381. PubMed ID: 28290206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence in protein derived nanomedicine as anticancer therapeutics: More than a tour de force.
    Wang Z; Zhi K; Ding Z; Sun Y; Li S; Li M; Pu K; Zou J
    Semin Cancer Biol; 2021 Feb; 69():77-90. PubMed ID: 31962173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound robotics for precision therapy.
    Del Campo Fonseca A; Ahmed D
    Adv Drug Deliv Rev; 2024 Feb; 205():115164. PubMed ID: 38145721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
    Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
    Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DePEGylation strategies to increase cancer nanomedicine efficacy.
    Kong L; Campbell F; Kros A
    Nanoscale Horiz; 2019 Mar; 4(2):378-387. PubMed ID: 32254090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Progress in Magnetically Actuated Microrobots for Targeted Delivery of Therapeutic Agents.
    Choi J; Hwang J; Kim JY; Choi H
    Adv Healthc Mater; 2021 Mar; 10(6):e2001596. PubMed ID: 33331143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approaches in extracellular vesicle engineering for improving the efficacy of anti-cancer therapies.
    Jayasinghe MK; Tan M; Peng B; Yang Y; Sethi G; Pirisinu M; Le MTN
    Semin Cancer Biol; 2021 Sep; 74():62-78. PubMed ID: 33609665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A diatom-based biohybrid microrobot with a high drug-loading capacity and pH-sensitive drug release for target therapy.
    Li M; Wu J; Lin D; Yang J; Jiao N; Wang Y; Liu L
    Acta Biomater; 2022 Dec; 154():443-453. PubMed ID: 36243369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.